TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT03969823 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01703949 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01859715 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04242056 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04242056 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT02196168 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT04081428 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04081428 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04101006 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02017561 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT02017561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02017561 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03217799 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT03560414 — Surrogate Endpoint (SUR): Plasma ammonia
Study NCT01238978 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT00500708 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01013779 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT02383927 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT02028299 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT00495755 — Predictive Biomarker (PRD): CD52 mRNA
Genes: CD52; CDW52; HE5
Study NCT01688895 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study NCT04438460 — Pharmacodynamic Biomarker (PDY): Human leukocyte antigen DR
Study NCT00428246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01621867 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02960321 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT02082106 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03023163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00442897 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03527719 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00342498 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01704703 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01704703 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT01545050 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02869347 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT02846935 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03074825 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03074825 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03152786 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT03152786 — Predictive Biomarker (PRD): BAD mRNA
Genes: BAD; BBC6; BCL2L8
Study NCT03101709 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02438345 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT02291926 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00509821 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT00901550 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00937547 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04479514 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT02179853 — Safety Biomarker (SAF): Interleukin 1
Study NCT04701775 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04701775 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01806064 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01722292 — Predictive Biomarker (PRD): SMO mRNA
Genes: SMO; SMOH
Study NCT00712192 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT04931030 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00815932 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT03124368 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT02074358 — Surrogate Endpoint (SUR): Change in coagulation parameter
Study NCT00885794 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04187976 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT02519868 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01670565 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05588544 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01919346 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02222883 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02819024 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00499135 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00499135 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT00668330 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02514499 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00867529 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01257594 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01922622 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02545959 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01114360 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02231242 — Predictive Biomarker (PRD): TNC mRNA
Genes: TNC; HXB
Study NCT01120184 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02521012 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03605069 — Predictive Biomarker (PRD): COL7A1 mRNA
Genes: COL7A1
Study NCT00673881 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00673881 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01565252 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01895244 — Predictive Biomarker (PRD): CYCS mRNA
Genes: CYCS; CYC
Study NCT04170192 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT01529333 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00436254 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00436254 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02295748 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT01648985 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00508014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02560636 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03374202 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04423042 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01898793 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03320213 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT01813565 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03830697 — Predictive Biomarker (PRD): POR mRNA
Genes: POR; CYPOR
Study NCT01742988 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01742988 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT01742988 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study NCT00301041 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study NCT01543906 — Predictive Biomarker (PRD): RPE65 mRNA
Genes: RPE65
Study NCT04047290 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04313322 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03386734 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study NCT02694588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02655822 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT00463580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00463580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00463580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03283566 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00889200 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT04652128 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01020942 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study NCT00275756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00917813 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02274623 — Surrogate Endpoint (SUR): Serum calcium
Study NCT02274623 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00865228 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02690454 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study NCT00192452 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT04002765 — Predictive Biomarker (PRD): MUC5B mRNA
Genes: MUC5B; MUC5
Study NCT02569801 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02569801 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02569801 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02880813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00777699 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT00777699 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00201123 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01648478 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC2A4 mRNA
Genes: SLC2A4; GLUT4
Study NCT00237380 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03375372 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04191785 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04427878 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04427878 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04104035 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT04104035 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04104035 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT04104035 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04104035 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04104035 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01912248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01753596 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT03381417 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01327027 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT00535886 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00353093 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT01274559 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00514020 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT01055678 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01055678 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04222855 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04484246 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03635840 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT02673554 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02204072 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03495271 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02090179 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03961997 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03330717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03264547 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03167320 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT02248129 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04052932 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT01195467 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01730495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00033189 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT02929706 — Safety Biomarker (SAF): Nucleotide triphosphate diphosphatase NUDT15
Genes: NUDT15; MTH2
Study NCT03756064 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03410342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04659070 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04659070 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01703481 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04326686 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04432350 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03438435 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04295434 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01446861 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT01459913 — Predictive Biomarker (PRD): IFNL3 mRNA
Genes: IFNL3; IL28B; IL28C; ZCYTO22
Study NCT01658956 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01658956 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT00861016 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02206113 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00363649 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05188872 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT03261349 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study NCT02574741 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04428138 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study NCT01860417 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT00149708 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00667342 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00667342 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01479634 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02103478 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT00898911 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01127399 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT06360588 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04098978 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01387724 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study NCT01387724 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study NCT01290783 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03814694 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04024423 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT01314924 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00588913 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01271543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00401336 — Predictive Biomarker (PRD): Liver iron
Study NCT02035722 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT02035722 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02035722 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03553485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03553485 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04054648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02439775 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00031564 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00293345 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT02592577 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT04265937 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04265937 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04265937 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04265937 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT04265937 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT02298738 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00003027 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01172548 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01172548 — Predictive Biomarker (PRD): KIT
Genes: CD117; SCFR; C-Kit
Study NCT04251533 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04251533 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT03819712 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02999958 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00806598 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT00806598 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04219163 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02606097 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01663298 — Predictive Biomarker (PRD): FGF2 mRNA
Genes: FGF2; FGFB
Study NCT00897754 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01705145 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT01705145 — Predictive Biomarker (PRD): CFTR
Genes: MRP7; ABC35; TNR-CFTR; dJ760C5.1; CFTR/MRP
Study NCT02108418 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02859558 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01953900 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02513316 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT02513316 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT04085523 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT01649856 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03377725 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT03377725 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01142739 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study NCT03562416 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03562416 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03792685 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT03792685 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01162187 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00259558 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT00157690 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02102139 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01700023 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01504009 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04047771 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00053807 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02576080 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT04720859 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT04898231 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1